Tom Boyd – Chairman
Mr. Boyd has served on the Company’s Board of Directors since the Company was incorporated in April 2005. He is the founder and past CEO of Fi-Shock, Inc., founder and past CEO of Mark Electronics, founder and past CEO of I-Shop, Inc, and founder and past CEO of The Boyd Group. Mr. Boyd has served as a Director of Radio Systems, Inc. (PetSafe™) since it’s organization in 1991.
Eric Mayer – Chief Executive Officer
Mr. Mayer was appointed CEO in 2015, and previously served as the Company’s VP of Business Development from 2013-2015. Prior to EDP Biotech, Eric Mayer had directed business development at BioPet Vet Lab and developed veterinary diagnostic products at AAD, Inc. His experience in biomedical/pharmaceutical start-ups include Metabolon, Inc. and Cirrus Pharmaceuticals. He received his Bachelor’s in Biochemistry from UNC-Chapel Hill, and his Master’s of Microbial Biotechnology (MMB) and Master’s of Business Administration (MBA) from North Carolina State University.
Jason Liggett, Ph.D. – Laboratory Manager
Jason Liggett, a Knoxville native, comes to EDP Biotech with experiences in both clinical and research sciences related to colorectal cancer. His doctorate studies in Comparative and Experimental Medicine focused on molecular mechanisms of non-steroidal anti-inflammatory drugs (NSAIDs) and their effects in human colorectal cancer. He worked in translational medicine in the core laboratory at University of Tennessee Medical Center and as a senior IVD scientist in developing colorectal cancer tests for more than 8 years. He is the primary/secondary author on more than 20 publicans, presentations and awards. He holds a Bachelor’s in Medical Technology and a Ph.D. in Comparative and Experimental Medicine from the University of Tennessee.
Olivia McGhee – Director, Finance and Operations
Olivia McGhee, a Knoxville native, comes to EDP Biotech with more than 20 years of Accounting and Business Management experience. Her tenure at prior companies such as Lauren Engineers & Constructors and AMEC Engineers, has provided an accomplished skill set widespread in these areas. Because of a take action and teamwork mentality she has excelled and helped management succeed to meet goals. Her community focus involves various organizations including her church and Little League. Along with her faith, personality and hard work ethic, Olivia brings an excitement and energy to the company in helping it thrive and grow to the next level. She received her Certified Bookkeeper Certification from the University of Tennessee.
Dennis Forbush – QA/RA and Manufacturing Consultant
Dennis Forbush served as EDP Biotech’s Director of QA/RA and Manufacturing Liaison from 2015-2016 and currently Consults with the Company. He is responsible for the implementation and oversight of the Quality Management System and Contract Management. The Regulatory Affairs responsibilities include review of CE Certification and 510(k) submissions.
During his ten year tenure in the Healthcare and Biotech industry, Dennis’s roles have included Quality and Compliance Officer, Project Manager and Quality Engineer with additional responsibilities as the Management Representative with specific focus on CAPA, the Customer Complaint Handling System, Document Control, Internal Audits and Training Programs. As the Safety Officer, he implemented and maintained the Environmental, Health and Safety Program as well as the Radiation Safety Program. His efforts have culminated into ISO 13485 and CMDCAS Certifications. Dennis holds a B.A. in Organizational Management from Concordia University in St Paul, MN and an A.A. in Aerospace Engineering from the US Air Force.
Anton Jansen – International Sales Consultant
Anton Jansen has 25 years of experience in the global medical device healthcare industry with demonstrated success in developing new international markets for innovative diagnostic products to include the PLAC Test for diaDexus; respiratory and sleep apnea devices for Tyco Healthcare (now Covidien); and Lipid Point of Care devices for Cholestech. He has built strong relationships with key opinion leaders with expertise in organizing clinical studies and seminars at major conferences. He has a B.S. in Chemistry and M.S. in Biochemistry from The Netherlands. Anton moved in 1995 to the US and is fluent in Dutch and German.
Lisa Jensen-Long – Marketing and BD Consultant
Lisa Jensen-Long has 25 years of experience with global commercialization in upstream and downstream marketing for both multi-national and start-up organizations. She has led life science and IVD marketing in product discovery, development and international commercialization with assays and platforms for Roche, HTG Molecular and Qiagen. She has demonstrated success in branding, creating both product and corporate awareness and driving customer engagement. She has driven regulatory and payer approvals in the US and internationally for IVD and CDx products in a variety of technology platforms. Lisa holds degrees from the University of Southern California and Arizona State University.